BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31939390)

  • 21. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Regular platelet donors--no risk to the donor].
    Offner R; Worschech W; Sänger W; Pachmann U
    Beitr Infusionsther Transfusionsmed; 1994; 32():341-4. PubMed ID: 9480122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
    Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
    J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and causes of pre-donation deferrals among potential plateletpheresis donors at a blood center in Eastern China.
    Zhu H; Wang J; Lin H
    Transfus Clin Biol; 2023 May; 30(2):189-194. PubMed ID: 36257581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demographic, laboratory, and operational variables that influence short- and long-term plateletpheresis yields.
    Badami KG; Sesun M; Basu A; Absalom N
    J Clin Apher; 2012 Nov; 27(5):247-54. PubMed ID: 22730096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Ironing out the risk': Assessing the effect of plateletpheresis donation frequency on iron stores in South-Asian male donors.
    Madkaiker D; Hiregoudar SS; Chavan P; Ojha S; Mendes J; Shastry S
    Vox Sang; 2023 Nov; 118(11):921-929. PubMed ID: 37772675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum ferritin in donors with regular plateletpheresis].
    Ma CH; Guo RH; Wu WJ; Yan JX; Yu JL; Zhu YH; He QT; Luo YH; Huang L; Ye RY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):508-10. PubMed ID: 21518519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis.
    Dettke M; Hlousek M; Kurz M; Leitner G; Rosskopf K; Stiegler G; Stohlawetz P; Worel N; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):449-53. PubMed ID: 9633557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, risk factors, and ferritin testing to mitigate iron depletion in male plateletpheresis donors.
    Spencer BR; Haynes JM; Notari EP; Stramer SL
    Transfusion; 2020 Apr; 60(4):759-768. PubMed ID: 32073674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of pre and post donation changes in hematological parameters and serum calcium and magnesium levels in plateletpheresis donors.
    Syal N; Kukar N; Arora H; Kaur A; Handa A; Maharishi RN
    J Family Med Prim Care; 2022 Apr; 11(4):1489-1492. PubMed ID: 35516708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort.
    Flesch BK; Adamzik I; Steppat D; Miller J; Carstensen L; Schapke M; Davey J
    Transfusion; 2010 Apr; 50(4):894-901. PubMed ID: 19951314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
    Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
    Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccine humoral response in frequent platelet donors with plateletpheresis-associated lymphopenia.
    Laumaea AE; Lewin A; Chatterjee D; Marchitto L; Ding S; Gendron-Lepage G; Goyette G; Allard MÈ; Simard C; Tremblay T; Perreault J; Duerr R; Finzi A; Bazin R
    Transfusion; 2022 Sep; 62(9):1779-1790. PubMed ID: 35919021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe CD4+ T-cell lymphopenia is not observed in frequent plateletpheresis donors collected on the Fenwal Amicus.
    Gansner JM; Papari M; Goldstein J; Gaufberg RA; Neuberg D; Makar RS; Kaufman RM
    Transfusion; 2019 Sep; 59(9):2783-2787. PubMed ID: 31271458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocytopenia in donors undergoing regular platelet apheresis with cell separators.
    Robbins G; Petersen CV; Brozović B
    Clin Lab Haematol; 1985; 7(3):225-30. PubMed ID: 4075737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of iron stores in regular plateletpheresis donors.
    Page EA; Coppock JE; Harrison JF
    Transfus Med; 2010 Feb; 20(1):22-9. PubMed ID: 19903323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis.
    Unay Demirel O; Ignak S; Buyukuysal MC
    Indian J Hematol Blood Transfus; 2018 Oct; 34(4):684-690. PubMed ID: 30369741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia.
    Siti Nadiah AK; Nor Asiah M; Nur Syimah AT; Normi M; Anza E; Aini AN; Mohd Zahari TH; Shahnaz M; Faraizah AK; Faisal MA
    Transfus Apher Sci; 2013 Dec; 49(3):507-10. PubMed ID: 24055412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.